| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |